Claim your FREE Gift & Newsletter. Just enter your... E-MAIL ADDRESS

First Name

Then

Don't worry -- your e-mail address is totally secure.
I promise to use it only to send you Prospering With Arthritis.


Get Back Into the Swing of Things!

Get the Best Bang for Your Buck... Click Here

If  this website was helpful, 
Please
Click below to... 
   


Joint Pain Forum – News you can use!

back to Arthritis News articles


Genzyme seeks OK on osteoarthritis drug



CAMBRIDGE, Mass., June 20 (UPI)

Genzyme said Wednesday it has filed for U.S. approval of Synvisc-One, a treatment used once every six months to treat osteoarthritis pain in the knee.

The company said that, if approved, its injectable drug would be the first to provide six months' pain relief in a single treatment.

Genzyme said it expects the Food and Drug Administration to take action on its application by the end of the year.






"The submission for approval of Synvisc-One is based on positive data which demonstrated that combining three doses of Synvisc in a single treatment is safe and effective in providing pain relief for up to six months in patients with knee osteoarthritis," said Ann Merrifield, president of Genzyme Biosurgery.

Genzyme's current Synvisc dosage form is delivered via three intra-articular doses of 2 milliliters each, administered at one-week intervals. Synvisc-One combines the three doses into one 6 milliliter injection.

SOURCE: The European League Against Rheumatism

back to Arthritis News articles













Bookmark This Page...
AddThis Social Bookmark Button
                                                

MEMBERS AREA | Site Map | CONTACT US
Privacy | Terms

About Us